The researchers identified the DMTF1 protein as a key regulator that declines with age, and they successfully restored neural stem cell renewal by reactivating its specific genetic pathways in both human-derived cells and mouse models. However, it remains unclear if this approach is safe from cancer risks or if it can be effectively delivered as a drug to improve memory in living human brains.
